Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Dr. Reddy's Laboratories Ltd (NY: RDY )

71.06 USD -0.95 (-1.32%)
Official Closing Price Updated: 7:00 PM EST, Jan 15, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 164,000
Open 71.05
Bid (Size) 70.33 (5)
Ask (Size) 71.40 (1)
Prev. Close 72.01
Today's Range 70.60 - 71.44
52wk Range 33.33 - 73.50
Shares Outstanding 165,999,034
Dividend Yield 0.39%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Dr. Reddy’s Receives Approval to Conduct Phase 3 Clinical Trial for Sputnik V Vaccine in India
Dr. Reddy’s Laboratories Ltd (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY) announced today that it has received approval from the Drugs Control General of India (DCGI) to conduct phase 3... 
From Business Wire News Releases
Sputnik V meets the primary endpoint of safety in the Phase 2 Clinical Trial in India
Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY) announced today that the independent Data and Safety Monitoring Board (DSMB) has reviewed the safety data from the phase 2 clinical... 
From Business Wire News Releases

Performance

YTD
-0.22%
-0.22%
1 Month
+4.22%
+4.22%
3 Month
+4.59%
+4.59%
6 Month
+29.22%
+29.22%
1 Year
+66.89%
+66.89%

More News

Read More
Dr. Reddy's Laboratories announces the launch of Febuxostat Tablets in the U.S. Market
From Business Wire News Releases
Dr. Reddy's to Release Q3 FY 21 Results on January 29th, 2021
From Business Wire News Releases
Dr. Reddy's Laboratories, Global Response Aid, and Appili Therapeutics Announce the Filing of an Application for REEQONUS™ (favipiravir) Tablets for the Treatment of COVID-19 under Health Canada’s Int
From Business Wire News Releases
P/E Ratio Insights for Dr Reddy's Laboratories
Tags Intraday Update Market News Markets
From Benzinga
Secondary Listing of Dr. Reddy’s ADRs on NSE IFSC Limited (GIFT City, Gujarat, India)
From Business Wire News Releases
3 Top Biotech Picks for 2021
Tags BMY CRSP ZYME
From Motley Fool
IBD Rating Upgrades: Dr Reddys Labs Flashes Improved Technical Strength
From Investor's Business Daily
Stocks With Rising Relative Strength: Dr Reddys Labs
From Investor's Business Daily
3 Top Biotech Stocks to Buy Right Now
Tags BMY CRSP Market News
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.